Cargando…
Treating Respiratory Viral Diseases with Chemically Modified, Second Generation Intranasal siRNAs
Chemically synthesized short interfering RNA (siRNA) of pre-determined sequence has ushered a new era in the application of RNA interference (RNAi) against viral genes. We have paid particular attention to respiratory viruses that wreak heavy morbidity and mortality worldwide. The clinically signifi...
Autor principal: | Barik, Sailen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120413/ https://www.ncbi.nlm.nih.gov/pubmed/19301655 http://dx.doi.org/10.1007/978-1-60327-547-7_16 |
Ejemplares similares
-
Therapy of Respiratory Viral Infections with Intranasal siRNAs
por: Barik, Sailen, et al.
Publicado: (2014) -
Intranasal Delivery of Antiviral siRNA
por: Barik, Sailen
Publicado: (2010) -
siRNA for Influenza Therapy
por: Barik, Sailen
Publicado: (2010) -
siRNAmod: A database of experimentally validated chemically modified siRNAs
por: Dar, Showkat Ahmad, et al.
Publicado: (2016) -
Respiratory viral diseases: access to RNA interference therapy
por: Bitko, Vira, et al.
Publicado: (2007)